Optimal Target HbA1c, Genetic Risks for Pancreatic Cancer, US Trends in Obesity, and more

JAMA Editor’s Summary

Optimal Target HbA1c, Genetic Risks for Pancreatic Cancer, US Trends in Obesity, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the

June 19, 2018

Listen on your favorite player Take me to this show’s page

Newer →

Fruquintinib for Refractory Metastatic CRC, Abortion Facility Type and Procedural Complications, Screening for Osteoporosis, and more

← Older

Wound Management in LE Open Fractures, Medications That Cause Depression, Screening ECG Guideline, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Optimal Target HbA1c, Genetic Risks for Pancreatic Cancer, US Trends in Obesity, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 19, 2018 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00